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305 Comparison of contacts to adult and paediatric cystic ﬁbrosis
Clinical Nurse Specialists
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S. Carr2, C. Lambert2. 1Barts and the London NHS Trust, Adult Cystic Fibrosis
Service, London, United Kingdom; 2Barts and the London NHS Trust, Paediatric
Cystic Fibrosis Service, London, United Kingdom
Introduction: Clinical Nurse Specialists (CNS’s) are commonly the primary point
of contact in cystic ﬁbrosis (CF) centres.
Aim: To identify and compare preferred modes of contact to paediatric (P)
and adult (A) CF CNS’s for healthcare users. To identify when patients take
responsibility for their own management.
Method: P and A CF CNS’s prospectively recorded how, why and by whom they
were contacted over a 30 day calendar month. CNS’s were available via telephone
and email. The P team have a pager for messaging, A CNS’s have a mobile
telephone.
Results: 340 contacts were received (130 P, 210 A) from clinics of 130 P and
147 A patients. Contact methods: phone 57% P vs 75% A, email 12% P vs 7% A.
Pager 31% P vs mobile texts 18% A. No children initiated contact in the P clinic.
2/12 patients <18 years in the A clinic initiated contact. All contacts were from
the patients after the age of 18 years. 12 contacts to the P CNS were from Health
Care Professionals (e.g. GP, community nurse). Reasons for contact: Respiratory
management 42% P vs 39% A. 30% of the A contacts were for administrative
issues, e.g. outpatient appointments or admission dates, vs 6% in P. Referral on to
other team members was necessary in 12% P vs 21% A.
Conclusions: Patients <18 yrs rarely take responsibility for their own management
by contacting their CF CNS, leaving this to parents. Email contact was lower
than anticipated in both P and A centres. There was a higher per capita rate of
contact from the adult patients 1.4 vs 1, as well as a higher need for further MDT
involvement, possibly reﬂecting their increasing medical needs. This age group
utilise technology to contact their CNS’s less than expected.
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We have been running a cystic ﬁbrosis (CF) transition clinic since 2007, after a
local survey established the need for a transitional care pathway for young people
with CF between our paediatric and adult centres.
Objective: Our aim was to establish the effectiveness of our current CF transiitional
care pathway.
Methods: The audit took the form of a patient questionnaire. Participants were
aged between 17 and 22 years, had to have attended the transition clinic and still
be in attendance at the local adult centre to be eligible.
The questionnaire was hand delivered to all eligible patients either at clinic or during
a hospital admission over a 3 month period. The questionnaire was constructed of
both open and closed questions and included a number of ‘free text’ sections. We
incorporated the use of a Likert scale for two of the questions which focussed
speciﬁcally on individual knowledge of disease and ability to manage day-to-day
care.
Conclusion: Overall there was a 59% response rate. All young people transferred
to adult care by their eighteenth birthday, all transfer dates planned in advance and
all but two respondents felt they were ‘ready to transfer’ at the time they did.
Using a Likert scale showed a signiﬁcant difference in the knowledge base of
individuals compared to the conﬁdence they felt in managing their daily care.
The audit also highlighted to us that the provision of information young people
received about their disease was unsatisfactory and that improvements in educational
material would overall enhance the transitional care we provide.
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Background: Peripherally inserted central catheters (PICC) are frequently used in
patients with cystic ﬁbrosis (CF) for iv antibiotic treatment. Many patients prefer re-
peated PICC insertion instead of a total implantable venous access device (TIVAD).
Method: The use of PICC in our CF population (n = 287) was evaluated retrospec-
tively from February 2006 until October 2011. Events registered included: frequency
of PICC insertions; number of catheter days; problems reported by patients, ward
nurses and homecare team; number and type of interventions.
Results: During the study period 234 PICC have been inserted in 62 patients
(169 PICC in 39 adults [2385 days] and 65 PICCs in 23 children [1035 days]). Mean
(min–max) catheter dwell time was 14 days (4−31 days in children; 2−56 days in
adults).
In children insertions were done under general anesthesia (13) or under an analgesic
gas (18) (meopa). In all other cases a local anesthetic was used.
Minor problems were reported:
1. vascular access problems occurred in 11 (4.7%)
2. catheter loss due to accidental removal in 3 (1.3%), curled catheter (1) or catheter
leakage (2)
3. catheter obstruction in 13 (5.6%)
4. insertion site related problems in 13 (5.6%)
5. general side effects in 2 (0.9%)
Three of the 7 events involving vein stenosis occurred in patients who had4 PICCs
inserted at the same side in 1 year.
Discussion: PICCs can be used safely in patients with CF who require iv antibiotic
treatment. Serious complications are rare, minor problems may occur, especially
in patients with repeated PICC insertion. Additional data are needed to assess
the safety of repetitive PICC insertion and the need for vascular imaging before
insertion.
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Background: Adherence to treatment, especially prescribed medication, is essential
for good CF care. In the UK, although CF patients are cared for in specialist
centres most of their therapies are prescribed and dispensed in primary care, making
adherence assessment problematic. We wished to study this further.
Method: We looked at primary care medication and dispensing lists and compared
them with hospital records in 51 adult CF patients attending the annual screen
clinic.
Results: The primary care medication list was concordant with clinic records
in only 37 cases (72.5%). Regular monthly medication collections occurred in
29 cases (57%); a further 11 patients (21%) collected medications selectively and
2 patients (4%) did not collect any. In 9 patients (17%) the general practitioner was
unable to provide data regarding the medicines being issued. As regards adherence,
it was judged good in 55%, moderate in 11%, and poor in 9%.
Conclusions: The use of primary care medication lists facilitates the judgement
of adherence to therapy in CF. A small proportion of CF patients appear to have
poor medication adherence, and it is of concern that there was poor concordance
between hospital and primary care lists in a quarter of cases. The employment of
a specialised CF pharmacist may aid this.
